Intellipharmaceutics International Inc. is a listed company. Its insiders report their share dealings to SEDI. No insider at Intellipharmaceutics International Inc. has published a filing in the past twelve months. The most recent one dates from 27 November 2019.
Looking back to 2016, when coverage begins, insiders filed 8 purchases and no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
9 of 9 declarations
Intellipharmaceutics International Inc. is a pharmaceutical company focused on the development of generic and branded drugs. It is listed on the Toronto Stock Exchange under the symbol XTSE.